These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34990597)

  • 21. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.
    Taylor RW; Pyle A; Griffin H; Blakely EL; Duff J; He L; Smertenko T; Alston CL; Neeve VC; Best A; Yarham JW; Kirschner J; Schara U; Talim B; Topaloglu H; Baric I; Holinski-Feder E; Abicht A; Czermin B; Kleinle S; Morris AA; Vassallo G; Gorman GS; Ramesh V; Turnbull DM; Santibanez-Koref M; McFarland R; Horvath R; Chinnery PF
    JAMA; 2014 Jul; 312(1):68-77. PubMed ID: 25058219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic neuropathy, cardiomyopathy, cognitive disability in patients with a homozygous mutation in the nuclear MTO1 and a mitochondrial MT-TF variant.
    Charif M; Titah SM; Roubertie A; Desquiret-Dumas V; Gueguen N; Meunier I; Leid J; Massal F; Zanlonghi X; Mercier J; Raynaud de Mauverger E; Procaccio V; Mousson de Camaret B; Lenaers G; Hamel CP
    Am J Med Genet A; 2015 Oct; 167A(10):2366-74. PubMed ID: 26061759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in
    Robyns T; Willems R; Van Cleemput J; Jhangiani S; Muzny D; Gibbs R; Lupski JR; Breckpot J; Devriendt K; Corveleyn A
    Acta Cardiol; 2020 Dec; 75(8):748-753. PubMed ID: 31583969
    [No Abstract]   [Full Text] [Related]  

  • 24. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.
    Tischner C; Hofer A; Wulff V; Stepek J; Dumitru I; Becker L; Haack T; Kremer L; Datta AN; Sperl W; Floss T; Wurst W; Chrzanowska-Lightowlers Z; De Angelis MH; Klopstock T; Prokisch H; Wenz T
    Hum Mol Genet; 2015 Apr; 24(8):2247-66. PubMed ID: 25552653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy.
    Yang X; Li Z; Wang Q; Zhang Y; Zhao C
    Cardiol Young; 2022 Apr; 32(4):539-544. PubMed ID: 34180388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.
    Li L; Ma J; Wang J; Dong L; Liu S
    Eur J Med Res; 2022 Sep; 27(1):184. PubMed ID: 36155627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-exome sequencing reveals doubly novel heterozygous Myosin Binding Protein C and Titin mutations in a Chinese patient with severe dilated cardiomyopathy.
    Fan LL; Chen YQ; Huang H; Jin JY; Li JJ; Tan ZP
    Cardiol Young; 2018 Dec; 28(12):1410-1414. PubMed ID: 30109841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy.
    Becker L; Kling E; Schiller E; Zeh R; Schrewe A; Hölter SM; Mossbrugger I; Calzada-Wack J; Strecker V; Wittig I; Dumitru I; Wenz T; Bender A; Aichler M; Janik D; Neff F; Walch A; Quintanilla-Fend L; Floss T; Bekeredjian R; Gailus-Durner V; Fuchs H; Wurst W; Meitinger T; Prokisch H; de Angelis MH; Klopstock T
    PLoS One; 2014; 9(12):e114918. PubMed ID: 25506927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.
    Wang X; Yan Q; Guan MX
    Mitochondrion; 2009 Jun; 9(3):180-5. PubMed ID: 19460296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome Sequencing Diagnoses X-Linked Moesin-Associated Immunodeficiency in a Primary Immunodeficiency Case.
    Bradshaw G; Lualhati RR; Albury CL; Maksemous N; Roos-Araujo D; Smith RA; Benton MC; Eccles DA; Lea RA; Sutherland HG; Haupt LM; Griffiths LR
    Front Immunol; 2018; 9():420. PubMed ID: 29556235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation defect.
    Friederich MW; Geddes GC; Wortmann SB; Punnoose A; Wartchow E; Knight KM; Prokisch H; Creadon-Swindell G; Mayr JA; Van Hove JLK
    Mol Genet Metab; 2021 Aug; 133(4):362-371. PubMed ID: 34140213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.
    Huang S; Pu T; Wei W; Xu R; Wu Y
    J Gene Med; 2020 Mar; 22(3):e3146. PubMed ID: 31742804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first Korean cases of combined oxidative phosphorylation deficiency 35 with two novel TRIT1 mutations in two siblings confirmed by clinical and molecular investigation.
    Yoo S; Kim YA; Yoon JY; Seo GH; Keum C; Cheon CK
    Brain Dev; 2021 Feb; 43(2):325-330. PubMed ID: 32948376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation.
    Li X; Li R; Lin X; Guan MX
    J Biol Chem; 2002 Jul; 277(30):27256-64. PubMed ID: 12011058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenicity Analysis of a Novel Variant in
    Zhang Q; Ouyang Q; Xiang J; Li H; Lv H; An Y
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening.
    Haack TB; Gorza M; Danhauser K; Mayr JA; Haberberger B; Wieland T; Kremer L; Strecker V; Graf E; Memari Y; Ahting U; Kopajtich R; Wortmann SB; Rodenburg RJ; Kotzaeridou U; Hoffmann GF; Sperl W; Wittig I; Wilichowski E; Schottmann G; Schuelke M; Plecko B; Stephani U; Strom TM; Meitinger T; Prokisch H; Freisinger P
    Mol Genet Metab; 2014 Mar; 111(3):342-352. PubMed ID: 24461907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene screening and phenotype analysis in a pedigree with familial hypertrophic cardiomyopathy from Yunnan Province].
    Pang MJ; Ding XX; Zhang Y; Su WH; Zhang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):887-891. PubMed ID: 30462978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.